{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:20:57Z","timestamp":1776903657875,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T00:00:00Z","timestamp":1373846400000},"content-version":"vor","delay-in-days":195,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["respiratorycasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1016\/j.rmcr.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T17:17:17Z","timestamp":1382807837000},"page":"53-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Adalimumab induced pulmonary sarcoid reaction"],"prefix":"10.1016","volume":"10","author":[{"given":"S.","family":"Bhargava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2013.07.002_bib1","first-page":"46","article-title":"The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis","volume":"72","author":"Haraoui","year":"2005","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.rmcr.2013.07.002_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.semarthrit.2005.01.003","article-title":"Differentiating the efficacy of the tumor necrosis factor inhibitors","volume":"34","author":"Haraoui","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rmcr.2013.07.002_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomized trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.rmcr.2013.07.002_bib4","first-page":"201","article-title":"A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis","volume":"23","author":"Rossman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.rmcr.2013.07.002_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmcr.2013.07.002_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","article-title":"Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab","volume":"34","author":"Wallis","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rmcr.2013.07.002_bib7","first-page":"479","article-title":"Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis","volume":"16","author":"Kirson","year":"2013","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.rmcr.2013.07.002_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/RHU.0b013e3181efa190","article-title":"Tumor necrosis factor-alpha antagonist-induced sarcoidosis","volume":"16","author":"Clementine","year":"2010","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Da\u00efen","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmcr.2013.07.002_bib10","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3899\/jrheum.080383","article-title":"Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis","volume":"35","author":"Ognenovski","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2007.078840","article-title":"Relapse of sarcoidosis upon treatment with etanercept","volume":"67","author":"Louie","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmcr.2013.07.002_bib12","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3899\/jrheum.090307","article-title":"Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge","volume":"36","author":"van der Stoep","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.arbres.2010.05.011","article-title":"Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review","volume":"47","author":"Gifre","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2006.01949.x","article-title":"Granulomatous tattoo reaction in a patient treated with etanercept","volume":"21","author":"Bachmeyer","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000275676","article-title":"Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases","volume":"220","author":"Dhaille","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.rmcr.2013.07.002_bib16","first-page":"32","article-title":"Epithelioid cell granulomatosis of the lung: new insights and concepts","volume":"16","author":"Popper","year":"1999","journal-title":"Sarcoidosis, Vasculitis, Diffuse Lung Dis Off J WASOG\/World Assoc Sarcoidosis Other Granulomatous Disord"},{"key":"10.1016\/j.rmcr.2013.07.002_bib17","first-page":"609","article-title":"Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors","volume":"11","author":"Cathcart","year":"2012","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1346-8138.2010.00861.x","article-title":"Sarcoidosis during infliximab therapy for Crohn's disease","volume":"37","author":"Takahashi","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00063030-200317060-00005","article-title":"Tumour necrosis factor in sarcoidosis and its potential for targeted therapy","volume":"17","author":"Baughman","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.rmcr.2013.07.002_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1445-5994.2011.02612.x","article-title":"New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication","volume":"42","author":"Tong","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.rmcr.2013.07.002_bib21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/art.11154","article-title":"Pulmonary rheumatoid nodules in an etanercept-treated patient","volume":"48","author":"Hubscher","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmcr.2013.07.002_bib22","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rmcr.2013.07.002_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2796.2003.01074.x","article-title":"The cytokine network in sarcoidosis and its clinical relevance","volume":"253","author":"Ziegenhagen","year":"2003","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.rmcr.2013.07.002_bib24","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/j.1440-0960.2010.00660.x","article-title":"Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis","volume":"52","author":"Marcella","year":"2011","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10067-002-0654-5","article-title":"Anti-TNF-alpha-induced systemic lupus syndrome","volume":"22","author":"Debandt","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","article-title":"TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists","volume":"50","author":"Williams","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients","volume":"9","author":"Wollina","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11926-008-0072-z","article-title":"Vasculitis induced by tumor necrosis factor-targeted therapies","volume":"10","author":"Ramos-Casals","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rmcr.2013.07.002_bib29","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents","volume":"31","author":"Mohan","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmcr.2013.07.002_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.rmcr.2013.07.002_bib31","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/429998","article-title":"Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?","volume":"41","author":"Ehlers","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmcr.2013.07.002_bib32","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmcr.2013.07.002_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1034\/j.1399-3003.2000.16d31.x","article-title":"Genetic aspects in sarcoidosis","volume":"16","author":"Luisetti","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmcr.2013.07.002_bib34","first-page":"167","article-title":"Update on treatment of psoriatic arthritis","volume":"70","author":"Mease","year":"2012","journal-title":"Bull NYU Hosp Jt Dis"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007113000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007113000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T23:09:11Z","timestamp":1716073751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007113000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":34,"alternative-id":["S2213007113000294"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2013.07.002","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adalimumab induced pulmonary sarcoid reaction","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}